Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Suppressing ODC activity reduces tumor growth in hair follicles.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The document's conclusion cannot be provided because the document is not readable or understandable.